IDiyas

For the Inventor, By the Inventor

Suffern, NY, United States of America

Daniel B Moran

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 180(Granted Patents)


Company Filing History:

goldMedal16 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1977-1993

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5210193 - Piperazine derivatives (1993-05-11),
2. 4948894 - 8-fluoro and 7, 8, (1990-08-14),
3. 4940710 - 7-(substituted)piperaziny (1990-07-10),
4. 4923868 - 8-fluoro and (1990-05-08),
5. 4569934 - Imidazo[1,2-b]pyridazines (1986-02-11),
6. 4550166 - (Pyridinyl)-1,2,4-triazolo[4,3-a]pyridines (1985-10-29),
7. 4515791 - Substituted phenyl-1,2,4-triazolo[2,3-b]pyridazin-3(2H)ones as (1985-05-07),
8. 4374249 - [4R]-3-(.omega.-Aroylpropionyl)-4-thiazolidinecarboxylic acids and esters (1983-02-15),
9. 4293554 - Method of treating asthma (1981-10-06),
10. 4260756 - 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines (1981-04-07),
11. 4260755 - Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines (1981-04-07),
12. 4230705 - 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating (1980-10-28),
13. 4117130 - Method for treating anxiety in mammals (1978-09-26),
14. 4112095 - 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents (1978-09-05),
15. 4092311 - Hypotensive alkyl-3-[6-(aryl)-3-pyridazinyl]-carbazates (1978-05-30),

Title: The Innovations of Daniel B. Moran

Introduction

Daniel B. Moran is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 16 patents to his name, Moran's work has had a considerable impact on medical treatments.

Latest Patents

Moran's latest patents include innovative piperazine derivatives, specifically 7-(substituted)piperazinyl-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acids. These compounds, along with their pharmacologically acceptable salts, are designed for use in compositions aimed at treating bacterial infections in warm-blooded animals. Another significant patent involves 8-fluoro and 7, 8- novel substituted quinolinecarboxylic acid derivatives, which exhibit antibacterial activity. These compounds are crucial for developing methods to combat bacterial infections in animals.

Career Highlights

Moran has spent a considerable part of his career at American Cyanamid Company, where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also enhanced the understanding of antibacterial treatments.

Collaborations

Throughout his career, Moran has collaborated with esteemed colleagues such as Jay Donald Albright and George Rodger Allen, Jr. These partnerships have fostered innovation and have been vital in the development of new pharmaceutical solutions.

Conclusion

Daniel B. Moran's contributions to the field of pharmaceuticals through his numerous patents highlight his dedication to improving medical treatments. His innovative work continues to influence the development of effective antibacterial therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…